Mesoblast (MESO) Net Debt Issuances and Repayments (2022 - 2025)
Mesoblast's (MESO) quarterly Net Debt Issuances and Repayments came in at -$32.1 million in Q4 2025, down 32.15% year-on-year from -$47.3 million in Q4 2024, and down 32.15% quarter-over-quarter from -$24.3 million in Q4 2024.
Mesoblast (MESO) Net Debt Issuances and Repayments (2022 - 2025) Analysis & Trends
Mesoblast has disclosed Net Debt Issuances and Repayments across 4 years of filings, most recently posting -$32.1 million for Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | -32.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -32.10 Mn |
| Dec 31, 2025 | -32.10 Mn |
| Dec 31, 2024 | -24.29 Mn |
| Dec 31, 2024 | -24.29 Mn |
| Dec 31, 2023 | 10.44 Mn |
| Dec 31, 2023 | 10.44 Mn |
| Mar 31, 2023 | -11.46 Mn |
| Mar 31, 2023 | -11.46 Mn |
| Dec 31, 2022 | 11.17 Mn |
| Dec 31, 2022 | 11.17 Mn |